View in EDS

Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Saved in:
Bibliographic Details
Title: Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.
Authors: Freedland SJ; Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars‑Sinai Medical Center, 8635 West 3rd Street, 1070W, Los Angeles, CA, 90048, USA. Stephen.Freedland@cshs.org.; Durham VA Medical Center, Durham, NC, USA. Stephen.Freedland@cshs.org., Ribbands A; Adelphi Real World, Bollington, Cheshire, UK., Touya M; Astellas Pharma Inc., Northbrook, IL, USA., Butcher J; Adelphi Real World, Bollington, Cheshire, UK., Walley M; Adelphi Real World, Bollington, Cheshire, UK., Russell D; Pfizer Inc., New York, NY, USA., Bland CS; Pfizer Inc., New York, NY, USA., Ivanova JI; Pfizer Inc., New York, NY, USA.
Source: Advances in therapy [Adv Ther] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24.
Publication Type: Journal Article
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42340602
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freedland+SJ%22">Freedland SJ</searchLink>; Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars‑Sinai Medical Center, 8635 West 3rd Street, 1070W, Los Angeles, CA, 90048, USA. Stephen.Freedland@cshs.org.; Durham VA Medical Center, Durham, NC, USA. Stephen.Freedland@cshs.org.<br /><searchLink fieldCode="AU" term="%22Ribbands+A%22">Ribbands A</searchLink>; Adelphi Real World, Bollington, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Touya+M%22">Touya M</searchLink>; Astellas Pharma Inc., Northbrook, IL, USA.<br /><searchLink fieldCode="AU" term="%22Butcher+J%22">Butcher J</searchLink>; Adelphi Real World, Bollington, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Walley+M%22">Walley M</searchLink>; Adelphi Real World, Bollington, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Russell+D%22">Russell D</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bland+CS%22">Bland CS</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ivanova+JI%22">Ivanova JI</searchLink>; Pfizer Inc., New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2026 Jun 24. <i>Date of Electronic Publication: </i>2026 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42340602
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-026-03624-1
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freedland SJ
      – PersonEntity:
          Name:
            NameFull: Ribbands A
      – PersonEntity:
          Name:
            NameFull: Touya M
      – PersonEntity:
          Name:
            NameFull: Butcher J
      – PersonEntity:
          Name:
            NameFull: Walley M
      – PersonEntity:
          Name:
            NameFull: Russell D
      – PersonEntity:
          Name:
            NameFull: Bland CS
      – PersonEntity:
          Name:
            NameFull: Ivanova JI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 06
              Text: 2026 Jun 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1